Sveriges Riksbank
17.2.2026 09:30:00 CET | Globenewswire | Press release
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
| Bid date, 2026-02-17 | |
| Auction date | 2026-02-17 |
| Settlement date | 2026-02-18 |
| Maturity Date | 2026-02-25 |
| Nominal amount | 521 billion SEK |
| Interest rate | 1.75 % |
| Bid times | 09.30-10.00 (CET/CEST) on the Bid date |
| Bids are made to phone number | 08-696 69 70 |
| Confirmation of bids to e-mail | rbcert@riksbank.se |
| The lowest accepted bid volume | 1 million SEK |
| The highest accepted bid volume | 521 billion SEK |
| Allocation Time | 10.15 (CET/CEST) on the Bid date |
| Projected minimum liquidity surplus during the term | 521 billion SEK |
| Expected excess liquidity at full allotment | 0 billion SEK |
Stockholm, 2026-02-17
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ZenaTech Inc.17.2.2026 13:30:00 CET | Press release
ZenaTech Advances its Autonomous AI Drone Power Wash Platform and Dubai Drone as a Service Presence
Dyadic International, Inc.17.2.2026 13:25:00 CET | Press release
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
ICPO Foundation17.2.2026 13:17:56 CET | Press release
Prof. Lalith Kumar Shiyam Sundar, LMU Hospital Munich, received the ICPO Research Grant for “AI-driven Advancements in Precision Oncology”
FLSmidth A/S17.2.2026 13:05:03 CET | Press release
FLSmidth announces intention to initiate a new share buy-back programme of up to DKK 1.0 billion
Fortrea Holdings Inc17.2.2026 13:00:00 CET | Press release
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom